328 related articles for article (PubMed ID: 35393513)
1. mRNA-miRNA bipartite networks reconstruction in different tissues of bladder cancer based on gene co-expression network analysis.
Abedi Z; MotieGhader H; Hosseini SS; Sheikh Beig Goharrizi MA; Masoudi-Nejad A
Sci Rep; 2022 Apr; 12(1):5885. PubMed ID: 35393513
[TBL] [Abstract][Full Text] [Related]
2. mRNA-miRNA bipartite network reconstruction to predict prognostic module biomarkers in colorectal cancer stage differentiation.
Motieghader H; Kouhsar M; Najafi A; Sadeghi B; Masoudi-Nejad A
Mol Biosyst; 2017 Sep; 13(10):2168-2180. PubMed ID: 28861579
[TBL] [Abstract][Full Text] [Related]
3. Identifying the mRNAs associated with Bladder cancer recurrence.
Cao H; Cheng L; Yu J; Zhang Z; Luo Z; Chen D
Cancer Biomark; 2020; 28(4):429-437. PubMed ID: 32390597
[TBL] [Abstract][Full Text] [Related]
4. Identifying possible hub genes and biological mechanisms shared between bladder cancer and inflammatory bowel disease using machine learning and integrated bioinformatics.
Liu J; Wu P; Lai S; Wang J; Wang J; Zhang Y
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16885-16904. PubMed ID: 37740761
[TBL] [Abstract][Full Text] [Related]
5. Molecular network-based identification of competing endogenous RNAs in bladder cancer.
Jiang WD; Yuan PC
PLoS One; 2019; 14(8):e0220118. PubMed ID: 31369587
[TBL] [Abstract][Full Text] [Related]
6. Investigation of key miRNAs and target genes in bladder cancer using miRNA profiling and bioinformatic tools.
Canturk KM; Ozdemir M; Can C; Öner S; Emre R; Aslan H; Cilingir O; Ciftci E; Celayir FM; Aldemir O; Özen M; Artan S
Mol Biol Rep; 2014 Dec; 41(12):8127-35. PubMed ID: 25189652
[TBL] [Abstract][Full Text] [Related]
7. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
[TBL] [Abstract][Full Text] [Related]
8. Construction of miRNA-mRNA-TF Regulatory Network for Diagnosis of Gastric Cancer.
Fu Z; Xu Y; Chen Y; Lv H; Chen G; Chen Y
Biomed Res Int; 2021; 2021():9121478. PubMed ID: 34840985
[TBL] [Abstract][Full Text] [Related]
9. Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression.
Braicu C; Buiga R; Cojocneanu R; Buse M; Raduly L; Pop LA; Chira S; Budisan L; Jurj A; Ciocan C; Magdo L; Irimie A; Dobrota F; Petrut B; Berindan-Neagoe I
J Exp Clin Cancer Res; 2019 Oct; 38(1):433. PubMed ID: 31665050
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Gene Expression in Bladder Cancer: Possible Involvement of Mitosis and Complement and Coagulation Cascades Signaling Pathway.
Liu Y; Xiong S; Liu S; Chen J; Yang H; Liu G; Li G
J Comput Biol; 2020 Jun; 27(6):987-998. PubMed ID: 31545079
[TBL] [Abstract][Full Text] [Related]
11. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
[TBL] [Abstract][Full Text] [Related]
12. Gene co-expression network approach for predicting prognostic microRNA biomarkers in different subtypes of breast cancer.
Adhami M; MotieGhader H; Haghdoost AA; Afshar RM; Sadeghi B
Genomics; 2020 Jan; 112(1):135-143. PubMed ID: 30735795
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-related core genes and TF-miRNA-hub mrDEGs network in breast cancer.
Yan LR; Wang A; Lv Z; Yuan Y; Xu Q
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439992
[TBL] [Abstract][Full Text] [Related]
14. Identifying of miR-98-5p/IGF1 axis contributes breast cancer progression using comprehensive bioinformatic analyses methods and experiments validation.
Sun D; Luo X; Ma L; Wang Y; Zhang F
Life Sci; 2020 Nov; 261():118435. PubMed ID: 32950571
[TBL] [Abstract][Full Text] [Related]
15. Identification of Functional Genes in Pterygium Based on Bioinformatics Analysis.
Xu Y; Qiao C; He S; Lu C; Dong S; Wu X; Yan M; Zheng F
Biomed Res Int; 2020; 2020():2383516. PubMed ID: 33299863
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
17. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.
Jin N; Jin X; Gu X; Na W; Zhang M; Zhao R
Mol Med Rep; 2015 Aug; 12(2):3170-6. PubMed ID: 25955758
[TBL] [Abstract][Full Text] [Related]
18. The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.
Itesako T; Seki N; Yoshino H; Chiyomaru T; Yamasaki T; Hidaka H; Yonezawa T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
PLoS One; 2014; 9(2):e84311. PubMed ID: 24520312
[TBL] [Abstract][Full Text] [Related]
19. Identification of key miRNAs and mRNAs related to coronary artery disease by meta-analysis.
Liu L; Zhang J; Wu M; Xu H
BMC Cardiovasc Disord; 2021 Sep; 21(1):443. PubMed ID: 34530741
[TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.
Yao Y; Liu R; Gao C; Zhang T; Qi L; Liu G; Zhang W; Wang X; Li J; Li J; Sun C
J Cell Biochem; 2019 Sep; 120(9):15378-15388. PubMed ID: 31037764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]